Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Malgorzata Krajewska, Ph.D.

Concepts (70)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cyclin-Dependent Kinases220196750.700 Why?
DNA Damage2201924670.410 Why?
Chromosomal Instability120101650.380 Why?
DNA Repair2201920590.380 Why?
Mitosis2201312550.350 Why?
Xenopus Proteins120104540.320 Why?
Microtubule-Associated Proteins1201011050.270 Why?
Adrenergic Agents12022690.230 Why?
Evolution, Molecular1201019630.210 Why?
Drosophila Proteins1201017680.200 Why?
Polyadenylation120191130.170 Why?
RNA Processing, Post-Transcriptional120194450.140 Why?
Chromatography, Liquid120199620.140 Why?
Neuroblastoma1202211740.130 Why?
Chromatography, High Pressure Liquid1201916370.130 Why?
Pilocarpine22004690.130 Why?
Timolol22004530.130 Why?
Osteosarcoma120198900.130 Why?
Tandem Mass Spectrometry1201911160.120 Why?
Gene Dosage1201512700.100 Why?
Thiophenes220046010.090 Why?
Models, Molecular1201955350.090 Why?
Glaucoma, Open-Angle220046590.080 Why?
Phosphorylation1201987380.080 Why?
Xenopus laevis1201010130.070 Why?
DNA Copy Number Variations1201518990.070 Why?
Cell Line, Tumor22019169430.070 Why?
Sulfonamides2200419300.060 Why?
Intraocular Pressure2200411650.050 Why?
Drosophila melanogaster1201017790.050 Why?
Genomics1201553330.040 Why?
Gene Expression Regulation, Neoplastic1201586740.040 Why?
Drug Screening Assays, Antitumor120197580.040 Why?
Antihypertensive Agents2200420640.040 Why?
Gene Knockout Techniques120198170.040 Why?
Mice, SCID1201928420.030 Why?
Comparative Genomic Hybridization120155140.030 Why?
Cell Lineage1202226110.030 Why?
RNA, Neoplasm120157750.030 Why?
Humans820227151240.020 Why?
DNA Breaks, Double-Stranded120135880.020 Why?
Drug Combinations2200419410.020 Why?
Tumor Microenvironment1201930710.020 Why?
Cytokines1202272250.020 Why?
Animals320191707260.020 Why?
Neoplasms12015205150.020 Why?
Gene Regulatory Networks1201517110.020 Why?
Genetic Loci1201526140.020 Why?
Cell Cycle1201330200.020 Why?
Phenotype12022163710.020 Why?
Miotics1200480.020 Why?
Protein Kinase Inhibitors1201954820.010 Why?
Ocular Hypertension120031890.010 Why?
Cell Cycle Proteins1201335030.010 Why?
Double-Blind Method22004119000.010 Why?
RNA, Messenger12015132920.010 Why?
Cross-Over Studies1200420040.010 Why?
Safety1200312190.010 Why?
Gene Expression Profiling1201595210.010 Why?
Adrenergic beta-Antagonists1200412300.010 Why?
Models, Biological1201398950.010 Why?
Lung Neoplasms12019125670.010 Why?
Mice12019809950.010 Why?
Signal Transduction12013239730.010 Why?
Female320193773340.010 Why?
Treatment Outcome22004621860.000 Why?
Middle Aged220042148710.000 Why?
Prospective Studies12003511810.000 Why?
Male220043510810.000 Why?
Aged120041626740.000 Why?
Krajewska's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (70)
Co-Authors (12)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.